Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06084078

Rural Illinois Lung Cancer Screening Initiative

The role of this observational study is to access the feasibility of providing lung cancer screening using a designated nurse navigator through lung cancer screening clinic. Eligible participants will be identified using medical records, eligibility will be confirmed through phone call, screening visits will be scheduled as in-person visit or telehealth visit. Computed tomography screening will be performed at an approved center closer to the individuals place of living and results will be discussed during follow-up in-person visit or telehealth visit.

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sowmy Thuppal

Springfield, Illinois, 62704, United States

Location status: Recruiting

Location contact

About this study

The long-term goal is to establish healthcare practices to increase adherence to lung cancer screening among high-risk individuals. The overall objective in this application is to establish a lung cancer screening initiative to proactively identify and screen eligible patients for LDCT using a designated nurse practitioner (NP) along with telehealth. The central hypothesis is that use of a designated NP along with telehealth will increase lung cancer screening via LDCT among high-risk, racial/ethnic minority, and rural/sub-urban patients. The rationale for this proposal is use of a NP and telehealth will help overcome the barriers physicians face in identifying eligible patients for LDCT including collecting additional information to determine eligibility, discussing the pros and cons of LDCT, providing smoking cessation/abstinence counseling, making shared decisions, and documenting this information in the patients' charts.

In this prospective cohort study the nurse practitioner (NP) will proactively identify eligible individuals for LDCT using EMRs that are shared across the Department of Family and Community Medicine at SIU. These patients will be contacted and those agreeing to undergo screening will be given a referral to a nearby LDCT center. The NP will follow-up with the patients with the results of the LDCT and will refer them for further management to their primary care physician. If the results are negative for nodules then they will be followed up on a yearly basis until the participants are older than 80 years or have other life-threatening health issues.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All individuals 50-80 years of age
  • 20 pack-year smoking history
  • Currently smoke or have quit within the past 15 years:

Exclusion criteria

  • Individuals 49 years and below or 81 years and above
  • Has not smoked in 15 or more years
  • Individuals who develop a health problem that makes them unwilling or unable to have surgery if lung cancer is detected.

Treatment and study plan

Primary outcomes

  1. Screening rate

    Time frame: Through study completion, an average of 1 year

    Percentage of individuals screened (completed CT imaging) with and without telehealth

  2. Early stage diagnosis

    Time frame: Through study completion, an average of 1 year

    Percentage of individuals diagnosed with lung cancer at an early stage of the disease

Secondary outcomes

  1. Time to treatment initiation

    Time frame: Through study completion, an average of 1 year

    Number of days from diagnosis to treatment initiation will be calculated for each patient diagnosed with lung cancer

  2. Adherence to Screening

    Time frame: Through study completion, an average of 1 year

    Percentage of of individuals undergoing yearly screening with and without telehealth

  3. Cost

    Time frame: Through study completion, an average of 1 year

    Overall cost from pre-screening to screening and follow-up with and without telehealth

Study contacts

Contact information is provided by the study sponsor or research team.

Sowmy Thuppal, MD PhD

CONTACT

[email protected]

217-545-2320

Sponsors and collaborators

Lead sponsor

Southern Illinois University

Other

Registry information

Official study title

Patient Identification, Prescreening and LDCT Screening for Lung Cancer With Telehealth

Acronym: LDCT

Important dates

Study start
2024
Primary completion
2029
Study completion
2030
First posted
Oct 16, 2023
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.